← Browse by Condition
Medical Condition
oropharynx squamous cell carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05278039
Recruiting
Training Swallowing Initiation During Expiration
Enrollment
88 pts
Location
United States
Sponsor
Northwestern University
NCT07063212 Phase 2
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...